See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!
Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday.
More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.
Chemical Class · Nuclear Receptors
· See all 100+ product categories
| Item Number | Product | Sizes & Pricing | CAS | Purity | Image | Exclusive | Introduction Date | Mojo | Plain Text Name | Synonyms | Keywords | Interest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10008043 |
10- |
88127-53-1 | ≥98% |
|
2006-08-01 | 33.116261510129 | 10-nitrooleate | 10-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 9-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | 33.116261510129 | ||
| 18570 |
15- |
87893-55-8 | ≥95% |
|
87.065636974572 | 15-deoxy-12-14-prostaglandin-j2 | 15-deoxy-Δ12,14-PGJ2 | PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands 15dpgj2 atherosclerosis | 87.065636974572 | |||
| 18570.1 |
15- |
87893-55-8 | >98% (isomer mixture) |
|
72.258808208366 | 15-deoxy-12-14-prostaglandin-j2 | 15-deoxy-Δ12,14-PGJ2 | PPAR.gamma. PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands | 72.258808208366 | |||
| 10010132 |
15- |
- | ≥98% (isomer mixture) |
|
2008-06-09 | 19.581055862492 | 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester | 15-deoxy-Δ12,14-PGJ2-2-glycerol ester | PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic | 19.581055862492 | ||
| 10141 |
15- |
- | >98% |
|
2005-10-11 | 20.766694495600 | 15-deoxy-12-14-prostaglandin-j2-biotin | 15-deoxy-Δ12,14-PGJ2-biotin | affinity probes binding proteins cyclopentenones PGs prostaglandins peroxisomes proliferator-activated receptors PPARs anitmitotic antiproliferative genes expressions non-classical non-GPCR gene protein-coupled detected detection interactions biotins ligands complexes nuclear nucleic acids elucidations mechanisms biotinylated PGJ2 biotinamides | 20.766694495600 | ||
| 10007235 |
15- |
87893-55-8 | ≥97% |
|
2009-01-16 | 38.002247928177 | 15-deoxy-12-14-prostaglandin-j2-lipid-maps-ms-standard | 15-deoxy-Δ12,14-PGJ2 | PPARγ PPARgamma prostaglandins 15-deoxy-delta12,14-PGJ2 15-deoxy-d12,14-PGJ2 nuclear receptors 15-deoxy-Δ12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands atherosclerosis MS mass spectrometry standards | 38.002247928177 | ||
| 10007912 |
20- |
79551-84-1 | >98% |
|
✓ | 2007-08-15 | 47.112430939226 | 20-carboxy-arachidonic-acid | 20-COOH-AA | 20-HETE metabolites PPAR.alpha. PPAR.gamma. vasorelaxation activators CYP4F3B hypertension cytochrome P450 CYP450 perioxisome proliferator activated receptor PPARs PPARalpha PPARgamma | 47.112430939226 | |
| 10008842 |
2,3- |
1428-67-7 | ≥98% |
|
2007-07-26 | 70.018487569060 | 2-3-bis-4-hydroxyphenyl-propionitrile | DPN | estrogen receptors ER.beta. ER.alpha. SERM agonists transcription assays estrogens estradiol ERa ERb endocrinology | 70.018487569060 | ||
| 90500 |
3- |
116296-31-2 | ≥98% |
|
2004-02-06 | 1.169668508287 | 3-thiatetradecanoic-acid | 3-TDA | thioether myristic analogs PPAR ligands peroxisome proliferator-activated receptors oleic acids D9-desaturases .DELTA.9-desaturases DELTA9-desaturases atherosclerosis | 1.169668508287 | ||
| 11031 |
6- |
459789-99-2 | ≥95% |
|
2012-03-14 | 21.123287671233 | 6-ecdca | INT 747; Obeticholic Acid | cholesterol cholestasis diabetes fibrosis receptors agonists calcification adipogenesis obesity FXR chenodeoxycholic acids CDCA ligands 6-ethyl CDCA 6 ethyl CDCA 6 CDCA livers fibrosis genes kidneys diseases atherosclerosis INT-747 | 21.123287671233 | ||
| 10008042 |
9- |
875685-44-2 | ≥98% |
|
2006-08-11 | 28.305948434622 | 9-nitrooleate | 9-nitro-9-trans-Octadecenoic Acid | oleic acids nitration 10-nitrooleate peroxynitrite myeloperoxidase MPO PPARg PPAR.gamma. PPARgamma LNO2 nitrolinoleate nitrated unsaturated fatty endogenous signaling ligands nitric oxides regioisomers OA-NO2 in vivo plasma phospholipids 3T3-L1 preadipocytes | 28.305948434622 | ||
| 34405 |
9(R)- |
107656-14-4 | ≥98% |
|
✓ | 4.589254143646 | 9-r-hete | hydroxy acids 9R-HETEs 9-HETEs fatty 9(r)-HETEs 9(R)HETEs | 4.589254143646 | |||
| 10007417 |
9- |
106689-24-1 | ≥98% |
|
2005-07-20 | 1.194226519337 | 9-thiastearic-acid | heteroatom-substituted fatty acids modulates extensions desaturating distribution phospholipids pools radiolabeled stearate oleate rat hepatocytes hepatoma cellshypolipidemic effects anti-obesity therapeutics | 1.194226519337 | |||
| 10007686 | Acetyl Podocarpic Acid Anhydride Exclusive | 344327-48-6 | ≥98% |
|
✓ | 2007-07-11 | 110.879739103745 | acetyl-podocarpic-acid-anhydride | APD | receptors ABC1 ABCA1 oxysterol cholesterol LXRalpha LXR.alpha. LXRbeta LXR.beta. 7.alpha.-hydroxylase RXR retinoid agonists nuclear receptors atherosclerosis acetyls podocaysics acids anhydrides livers hormones atherosclerosis | 110.879739103745 | |
| 600130 |
ATF2 (Phospho- |
- |
|
2009-11-11 | 22.910218483173 | atf2-phospho-thr69-71-transcription-factor-assay-kit | Activating Transcription Factor 2 | kits measuring measurement assays tf activating DNA-binding proteins bZIP octameric cyclic AMP-responsive elements CRE promoter regions genes mediates mediation DNA damage controls phosphorylation/activation inflammatory cytokines UV irradiation alkylating compounds cells cellular stressors pThr69,71 Thr69 Thr71 JNK/p38 homodimers heterodimers ATF/CREB Fos Fra2 c-Jun CREB ATF1 cycles control drug resistance apoptosis tumorigenesis insulin biosynthesis non-radioactive detection detecting nuclear extracts ELISA enzyme-linked immunosorbent assay double-stranded dsDNA colorimetric 69 71 phosphorylated | 22.910218483173 | |||
| 60924 | Azelaoyl PAF | - | >98% |
|
43.427316495658 | azelaoyl-paf | PPAR gamma oxidized LDL lipids agonist atherosclerosis nuclear receptors | 43.427316495658 | ||||
| 70790 | BADGE | 1675-54-3 | >85% |
|
46.671270718232 | badge | Bisphenol A diglycidyl ether | ligands ppar.gamma. ppargamma peroxisome proliferator-activated receptors antagonists nuclear receptors | 46.671270718232 | |||
| 11571 | Bexarotene New | 153559-49-0 | ≥98% |
|
2012-04-06 | 47.635666052793 | bexarotene | LGD 1069; SR 11247; Ro 26-4455; LG 100069; Targretin | retinoid X receptors ligands agonist RXR genes expression cancers alzheimers diseases apoptosis angiogenesis metastasis cells proliferations β-amyloid amyloids βamyloid LG 100069 1069 69 LG-100069 LG-1069 LG-69 LGD 1069 LGD-1069 LGD1069 LG100069 LG1069 LG69 RO 26-4455 RO26-4455 RO-26-4455 RO 264455 RO-264455 RO264455 SR 11247 SR-11247 SR11247 targret targretin targretyn targrexin | 47.635666052793 | ||
| 10009145 | Bezafibrate | 41859-67-0 | ≥98% |
|
2007-08-02 | 4.950850828729 | bezafibrate | Difaterol; Bezatrol; Bezalip; BM 15075; Benzofibrate | PPAR PPAR.alpha. PPAR.delta. PPAR.gamma. agonist Pan-PPAR cholesterol atherosclerosis metabolic syndromes LDL HDL proliferator-activated receptors diabetes low-density high-density lipoproteins atherosclerosis cardiovascular PPARa PPARd PPARg endocrinology fibrate | 4.950850828729 | ||
| 70750 | Caffeic Acid phenylethyl ester | 104594-70-9 | >98% |
|
25.961635359115 | caffeic-acid-phenylethyl-ester | 2-Phenylethyl Caffeate; CAPE; β-Phenylethyl Caffeate | NF kB NF-kB NF-.kappa.B inhibits inhibitors inhibition antioxidants nuclear transcription factors propolis antimitogenic anticarcinogenic immodulatory anti-inflammatory inflammation bee nuclear receptors NF-kappaB nfkb nf-kb NF-.kappa.B 132031-37-9 caffeiate | 25.961635359115 | |||
| 18590 | CAY10410 | 596104-94-8 | ≥98% (isomer mixture) |
|
74.621583793738 | cay10410 | 9,10-dihydro-15-deoxy-Δ12,14-Prostaglandin J2; 9,10-dihydro-15-deoxy-Δ12,14-PGJ2 | PPAR.gamma. PPARgamma prostaglandins 9,10-dihydro-15-deoxy-delta12,14-PGJ2 9,10-dihydro-15-deoxy-d12,14-PGJ2 9,10-dihydro-15-deoxy-.DELTA.12,14-PGJ2 peroxisome proliferator-activated receptors PPARs activators ligands oxidative stress | 74.621583793738 | |||
| 10006545 | CAY10464 Exclusive | 688348-37-0 | ≥98% |
|
✓ | 2005-10-25 | 17.578720190921 | cay10464 | resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar intracellular transcription factors PAHs hydrocarbons antagonists receptors | 17.578720190921 | ||
| 10006546 | CAY10465 Exclusive | 688348-33-6 | >98% |
|
✓ | 2005-09-09 | 17.266060564257 | cay10465 | resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar | 17.266060564257 | ||
| 10009017 | CAY10514 | 868526-38-9 | ≥98% |
|
2007-01-24 | 5.527983425414 | cay10514 | Methyl-8-hydroxy-8-(2-pentyl-oxyphenyl)-oct-5-ynoate | peroxisome proliferator-activated receptors aromatics analogs 8-HETEs 8S-HETE 8(S)-HETE agonists PPARa PPARalpha PPAR.alpha. PPARg PPARgamma PPAR.gamma.atherosclerosis | 5.527983425414 | ||
| 10012682 | CAY10585 | 934593-90-5 | ≥97% |
|
2008-11-06 | 48.964775059194 | cay10585 | Hypoxia Inducible Factor-1α Inhibitor | HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition | 48.964775059194 | ||
| 10009797 | CAY10591 Exclusive | 839699-72-8 | ≥98% |
|
✓ | 2008-04-21 | 39.731274401472 | cay10591 | Sirtuin 1 Activator 3; SIRT1 Activator 3 | p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic | 39.731274401472 | |
| 10012536 | CAY10592 Exclusive | 685139-10-0 | ≥98% |
|
✓ | 2009-02-26 | 26.856961325966 | cay10592 | selective PPARδ agonist HDLs LDLs TGs lipids metanolism plasma rats L6 cells lines APOB100 CETP-Tgn mice mouse transactivation assays CETPTgn CETP Tgn | 26.856961325966 | ||
| 13282 | CAY10599 Exclusive | 1143573-33-4 | ≥98% |
|
✓ | 2009-07-21 | 39.161461019030 | cay10599 | thiazolidinedione PPARs PPARγ agonist rosiglitazones BRL 49653 BRL49653 BRL-49653 diabetes TZDs | 39.161461019030 | ||
| 10010250 | Cellular Retinol Binding Protein 7 Polyclonal Antibody | - |
|
2007-10-16 | 5.946309392265 | cellular-retinol-binding-protein-7-polyclonal-antibody | Retinoid Binding Protein 7; cRBP7; RET7; Cellular Retinol Acid-Binding Protein IV | western blots WB ICC immunocytochemistry micronutrient cell growth differentiation CRBPs RBP4 RBP7 atherosclerosis blotting immunoblotting IHC immunohistochemistry | 5.946309392265 | |||
| 10007171 | Cetaben | 55986-43-1 | ≥98% |
|
2005-11-11 | 1.577348066298 | cetaben | Hexadecylamino-p-amino Benzoic Acid | clofibrate peroxisomes proliferator-activated receptors PPARalpha PPAR.alpha.-independent hypolipidemic activity reduces reduction serums triglycerides cholesterols concentrations peroxisomal enzymes inhibits synthesis hepatoma HepG2 cells reversible changes Golgi morphology blocked esters inhibitors fibrates class atherosclerosis endocrinology | 1.577348066298 | ||
| 10009524 | ChREBP DBD (human recombinant) | - | >85% by SDS-PAGE | 2007-04-12 | 1.953729281768 | chrebp-dbd-human-recombinant | GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14 | EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology CAS number # 352845-69-3 | 1.953729281768 | |||
| 10009753 | ChREBP DBD Western Ready Control | - | 2007-05-03 | 1.953729281768 | chrebp-dbd-western-ready-control | Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14 | WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology | 1.953729281768 | ||||
| 71730 | Ciglitazone | 74772-77-3 | ≥98% |
|
45.614659811745 | ciglitazone | U-63287; ADD 3878 | nuclear receptors antidiabetic diabetes thiazolidinedione PPAR gamma PPAR.gamma. Peroxisome Proliferator-activated receptors Ligands Binding domains antihyperglycemic atherosclerosis endocrinology | 45.614659811745 | |||
| 10956 | Clofibrate | 637-07-0 | ≥98% |
|
2004-09-14 | 10.768753836709 | clofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated nuclear receptors lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases homeostasis agonists selectivity atherosclerosis endocrinology fibrate | 10.768753836709 | |||
| 11174 | Ercalcitriol New | 60133-18-8 | ≥98% |
|
2012-02-21 | 56.356335282651 | ercalcitriol | 1,25-Dihydroxyvitamin D2; Ro 17-6218 | vitamins D receptors calcium calcitriol calcipotriol retinoid X metabolites liver kidneys VDR RXR genes transcription dihydroxyergocalciferol Ro-176218 Ro 176218 | 56.356335282651 | ||
| 10005368 | Fenofibrate | 49562-28-9 | ≥98% |
|
2004-09-15 | 12.769097605892 | fenofibrate | PPAR.alpha. PPARalpha ligands selective peroxisome proliferator-activated receptors nuclear fibrate agonists lipids dyslipidemia fatty acids b-oxidation beta-oxidation .beta.-oxidation hypolipidemic drugs cardiovascular diseases atherosclerosis endocrinology | 12.769097605892 | |||
| 10011269 | Fulvestrant | 129453-61-8 | ≥98% |
|
2009-02-24 | 23.630331491713 | fulvestrant | ICI 182,780; Faslodex® | estrogen receptors ER ERα agonist antagonist activator breast cancers hippocampus neurons ICI182780 ZD182780 ZD9238 ZM182780 | 23.630331491713 | ||
| 10008613 | GW 7647 | 265129-71-3 | ≥98% |
|
2006-08-02 | 21.838997632202 | gw-7647 | PPAR.alpha. peroxisome proliferator-activated receptor triglycerides lipid homeostasis transcription factor fibrate atherosclerosis endocrinology GW7647 | 21.838997632202 | |||
| 10011211 | GW 9578 Exclusive | 247923-29-1 | ≥98% |
|
✓ | 2008-05-23 | 26.156961325966 | gw-9578 | atherosclerosis PPAR.alpha. PPARalpha PPARa LDLs lipids nuclear receptors fibrates diabetes obesity peroxisome perliforetior-activated | 26.156961325966 | ||
| 70785 | GW 9662 | 22978-25-2 | ≥98% |
|
71.039342541436 | gw-9662 | GW-9662 GW9662 ligands ppar.gamma. ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis | 71.039342541436 | ||||
| 9000497 |
GW 9662- |
- | ≥99% deuterated forms (d1-d5) |
|
✓ | 2009-09-30 | 33.777096378146 | gw-9662-d5 | deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry GW-9662 GW9662 ligands ppar.gamma. γ ppargamma peroxisome proliferator-activated nuclear endocrinology receptors antagonists atherosclerosis TZDs thiaolidinediones PPARs | 33.777096378146 | ||
| 10010324 | Harmine | 442-51-3 | ≥98% |
|
2007-11-07 | 27.335911602210 | harmine | metabolic syndromes obesity diabetes PPAR.gamma. insulin sensitivity metabolism .beta.-carboline b-carboline alkaloids hyperglycemia signalling pathway inflammatory gene expression endocrinology | 27.335911602210 | |||
| 11512 | HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n10b7 | High Mobility Group Protein B1; HMG1 | high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB | 0E-12 | |||
| 11513 | HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New | - |
|
2012-01-16 | 0E-12 | hmgb1-monoclonal-antibody-clone-img19n15f4 | HMG1; High Mobility Group Protein B1 | high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC | 0E-12 | |||
| 75650 | Hyperforin | 11079-53-1 | ≥90% |
|
51.111450276243 | hyperforin | St. John's Wort Johns herbal herbs lipid signalling mediators cyp450-2D6 cytochromes cyp-2D6 steroid receptors SXR CYP-450-2D6 neuroscience endocrinology | 51.111450276243 | ||||
| 11305 | Kynurenine New | 2922-83-0 | ≥98% |
|
2012-02-27 | 3.048518081679 | kynurenine | 3-anthraniloyl-Alanine | typtophan pathways catabolism glioma typtophan-2,3-dioxygenase tumors AhR aryl hydrocarbons receptors quinolinic acid neurodegenerative diseases L-Kynurenine 3-anthraniloyl-alanine kynurenin | 3.048518081679 | ||
| 10004976 | Leptomycin B | 87081-35-4 | >98% |
|
2008-03-19 | 2.397790055249 | leptomycin-b | NSC 364372; Mantuamycin; LMB; Elactocin | antibiotics cell cycles p53 antifungals proliferation nuclear transport inhibits inhibitors inhibition inhibiting export signals receptors NES RNA REV-response elements HIV-1 4D 3E3 | 2.397790055249 | ||
| 10006318 | Levonorgestrel | 797-63-7 | >95% |
|
2005-01-25 | 81.679972375690 | levonorgestrel | Norplant | levonorgestrel progestins progesterones contraception steroids hormones replacement contraceptives uterine uterus pregnancy analogs ovulation inhibition inhibitors inhibits receptors PR endocrinology | 81.679972375690 | ||
| 90290 | MEDICA 16 | 87272-20-6 | >98% |
|
12.588950276242 | medica-16 | hypolipidemic antidiabetogenic analogs fatty acids diabetes antidiabetic b,b'-hexadecanedioic nuclear receptors beta,beta-hexadecanedioic .beta.,.beta.'-hexadecanedioic VLDL decrease atherosclerosis | 12.588950276242 | ||||
| 10006317 | Mifepristone | 84371-65-3 | >98% |
|
2005-01-25 | 108.466239147593 | mifepristone | RU-486 | progesterones estrogens estradiol cancers apoptosis RU486 uterine uterus pregnancy hormones receptors glucocorticoids steroids PR GR HRE response elements binding endocrinology | 108.466239147593 | ||
| 11633 | NCOR2/SMRT (human recombinant) New | - | ≥60% | 2012-04-09 | 85.995493155963 | ncor2-smrt-human-recombinant | TRAC; T3 Receptor-Associating Factor; Nuclear Receptor Corepressor 2; Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor; CTG Repeat Protein 26; SMRT; SMAP270; Thyroid-Retinoic-Acid-Receptor-Associated Corepressor | epigenetics histones deacetylases transcriptional regulations corepressor co-repressor complexes metabolism HDACs HDAC3 class I HDAC yeast Rpd DAD E2F TFIIE TFIIF NF-κB p300 Stat3 p53 retinoblastoma protein Rb protein differentiation cell death angiogenesis inflammation cancers inflammatory diseases | 85.995493155963 | |||
| 10009818 |
NF- |
- | >75% | 2007-06-20 | 24.009060773481 | nf-b-p50-human-recombinant | NF-κB1; Nuclear Factor-κB (p50) | transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b | 24.009060773481 | |||
| 10010184 |
NF- |
- | Whole cell lysate | 2007-07-19 | 23.556764009471 | nf-b-p50-western-ready-control | Nuclear Factor-κB (p50); NF-κB1 | western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals | 23.556764009471 | |||
| 10006319 | Norgestrel | 6533-00-2 | ≥95% |
|
2005-01-25 | 73.987629331993 | norgestrel | Ovrette® | levonorgestrel progestins progesterones contraception steroids hormones replacement estrogens contraceptives receptors PR uterine uterus pregnancy ovulation inhibition ihibits inhibitors endocrinology | 73.987629331993 | ||
| 10009277 | Nuclear Extraction Kit | - | 2007-05-11 | 80.119260282381 | nuclear-extraction-kit | assays kits proteins transcription factors cytoplasmic fractions cells tissue homogenates EMSA extracts electrophoretic mobility shift western blotting blots | 80.119260282381 | |||||
| 600060 |
p53 Total and p53 (Phospho- |
- |
|
2009-03-10 | 3.415837937385 | p53-total-and-p53-phospho-ser392-dual-staining-assay-kit | kits assays measuring measurements tumors treatments DyLightTM (-)-Nutlin-3 positive ontrols p53(Phospho-Ser392) dsDNA double-stranded suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous autosomal Li Fraumeni Syndromes nuclear extracts cell-based assays cell based assay cba | 3.415837937385 | ||||
| 71745 | Pioglitazone | 111025-46-8 | >98% |
|
24.079289660615 | pioglitazone | PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated rosiglitazone receptors activation selectively selectivity | 24.079289660615 | ||||
| 10028 | Pioglitazone (potassium salt) | - | >98% |
|
36.995177584846 | pioglitazone-potassium-salt | PPARgamma PPAR.gamma. anti-diabetic thiazolidinediones PPARalpha PPAR.alpha. RXRalpha RXR.alpha. agonists TZDs peroxisome proliferator-activated receptors | 36.995177584846 | ||||
| 301710 | PPARα Blocking Peptide | - | 7.624732965009 | ppar-blocking-peptide | Peroxisome Proliferator-activated Receptor α | peroxisome proliferator-activated receptors peptides controls pparalpha ppar.alpha. antibodies nuclear reactors | 7.624732965009 | |||||
| 10009088 | PPARα LBD (human recombinant) | - | ≥90% | 2006-09-13 | 56.225207182320 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor α Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting | 56.225207182320 | |||
| 101710 | PPARα Polyclonal Antibody | - |
|
26.564855739717 | ppar-polyclonal-antibody | Peroxisome Proliferator-activated Receptor α | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a antibodies ligands ligand-activated activates activated lipids homeostasis fatty acids FAAH NSAIDs prostaglandins PGs luekotrienes LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic drugs transcriptionally regulates regulated regulation genes enzymes proteins metabolism oxidation acyl-CoA CoA oxidase enol-CoA hydratase chains dehydrogenase transports cytochrome P450 4A isoenzymes northern blots blotting immunoblotting liver skeletal muscle hearts kidney amino acids Atherosclerosis | 26.564855739717 | ||||
| 10006915 | PPARα Transcription Factor Assay Kit | - |
|
2005-08-25 | 55.515160870978 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor α Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 55.515160870978 | |||
| 10008878 | PPARα, δ, γ Complete Transcription Factor Assay Kit | - |
|
2006-08-22 | 38.534629044988 | ppar-complete-transcription-factor-assay-kit | PPARα PPARδ PPARγ PPAR-α PPAR-δ PPAR-γ PPAR α PPAR δ PPAR γ PPARalpha PPARdelta PPARgamma PPAR-alpha PPAR-delta PPAR-gamma delta alpha gamma PPAR.alpha. PPAR.delta. PPAR.gamma. PPAR-.alpha. PPAR-.delta. PPAR-.gamma. .alpha. .gamma. .delta.peroxisomes proliferator-activated proliferator activated receptors PPARs completes TF factors assay kits atherosclerosis endocrinology metaboli syndrome metabolism nuclear obese obesity PPAR non-radioacitve radioactive DNA detecting whole cells lysates 96-wells 96 wells immunosorbent ELISA enzyme-links enzyme-linked enzyme links linked electrophoretic mobility shifts EMSA double stranded dsDNA HRP colorimetric | 38.534629044988 | ||||
| 301700 | PPARγ Blocking Peptide | - | 5.718549723756 | ppar-blocking-peptide | Peroxisome Proliferator-activated Receptor γ | peroxisome proliferators activated receptors controls immunohistochemistry IHC Western blotting WB PPAR.gamma. PPARgamma blots peptides antibodies | 5.718549723756 | |||||
| 61700 | PPARγ FL (human recombinant from E. coli) | - | >90% by SDS-PAGE |
|
2007-01-10 | 27.604745242480 | ppar-fl-human-recombinant-from-e-coli | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant) | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone | 27.604745242480 | ||
| 10009987 | PPARγ FL (human recombinant from Sf21 cells) | - | ≥80% by SDS-PAGE |
|
2007-06-15 | 33.559779005524 | ppar-fl-human-recombinant-from-sf21-cells | Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells) | proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology | 33.559779005524 | ||
| 10007941 | PPARγ LBD (human recombinant) | - | ≥90% |
|
2006-03-16 | 20.752995702885 | ppar-lbd-human-recombinant | Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent | 20.752995702885 | ||
| 71000 | PPARγ Ligand Pack | - | >98% | 44.918631062001 | ppar-ligand-pack | Peroxisome Proliferator-activated Receptor γ Pack | ligands ppar.gamma. ppargamma receptors antagonists antidiabetic diabetes peroxisome nuclear receptors proliferator-activated 15-deoxy-delta12,14-PGJ2 rosiglitazone ciglitazone troglitazone MCC-555 MCC555 thiazolidinediones TZD GW9662 GW-9662 15-deoxy-d12,14-PGJ2 15-deoxy-.DELTA.12,14-PGJ2 nuclear receptors pioglitazone (potassium salt) 71740 18570 71742 70735 71745 10004272 GW 501516 GW501516 atherosclerosis packs | 44.918631062001 | ||||
| 10007685 | PPARγ Ligand Screening Assay Kit | - |
|
2009-07-16 | 45.958161727774 | ppar-ligand-screening-assay-kit | Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green | FP-based peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists | 45.958161727774 | |||
| 101700 | PPARγ Polyclonal Antibody | - |
|
18.013737174427 | ppar-polyclonal-antibody | Peroxisome Proliferator-activated Receptor γ | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g antibodies ligands ligand-activated activated activates activated transcription factors lipids homeostasis regulator regulates adipogenesis mRNA tissues large small intestines kidneys livers genes PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ1 PPAR-γ-1 PPAR-gamma1 PPAR-gamma-1 PPAR-.gamma.1 PPAR-.gamma.-1 PPAR-g-1 PPAR-g1 PPARγ1 PPARgamma1 PPAR.gamma.1 PPAR-γ2 PPAR-γ-2 PPAR-gamma2 PPAR-gamma-2 PPAR-.gamma.2 PPAR-.gamma.-2 PPAR-g-2 PPAR-g2 amino acids western blots immunoblotting blotting WB atherosclerosis endocrinology metabolism nuclear receptors | 18.013737174427 | ||||
| 10006855 | PPARγ Transcription Factor Assay Kit | - |
|
2005-08-25 | 58.531583793738 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor γ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 58.531583793738 | |||
| 10006247 | PPARδ Blocking Peptide | - | >70% | 2004-11-09 | 2.702154696132 | ppar-blocking-peptide | PPARβ; Peroxisome Proliferator-activated Receptor δ; NR1C2 | controls peptides western blots WB immunoblotting antibodies receptors PPARbeta PPAR.beta. lipid metabolism obesity special:month specialdiscount:15 specialstart:2008-02-01 specialend:2008-02-29 | 2.702154696132 | |||
| 10007451 | PPARδ (human recombinant) | - | ≥95% | 2005-07-29 | 13.889472068754 | ppar-human-recombinant | NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 | 13.889472068754 | |||
| 101720 | PPARδ Polyclonal Antibody | - |
|
2004-11-05 | 14.570783525866 | ppar-polyclonal-antibody | Nuclear Hormone Receptor 1; NUC1; FAAR; PPARβ | PPAR.delta. PPAR.beta. PPARbeta peroxisome proliferator-activated receptors PPARdelta antibodies antisera nuclear receptors antiserum western blots blotting WB ICC immunocytochemistry IHC immunohistochemistry atherosclerosis endocrinology immunoblotting antibodies | 14.570783525866 | |||
| 10006914 | PPARδ Transcription Factor Assay Kit | - |
|
2005-08-23 | 30.800928867402 | ppar-transcription-factor-assay-kit | Peroxisome Proliferator-activated Receptor δ Transcription Factor Assay Kit | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d kits assys atherosclerosis endocrinology metabolic syndrom metabolism nuclear obese obesity transcription factors ligands hormones ELISA enzyme-linked enzyme linked immunosorbent EMSA electrophoretic mobility shifts PPRE response element adipokines TF | 30.800928867402 | |||
| 10009568 | PPARδ Western Ready Control | - | 2007-02-02 | 3.709790055248 | ppar-western-ready-control | Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1 | peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity | 3.709790055248 | ||||
| 10008841 | Propylpyrazole Triol | 263717-53-9 | ≥98% |
|
2007-01-25 | 89.196277624309 | propylpyrazole-triol | PPT | 17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology | 89.196277624309 | ||
| 11017 | Retinoic Acid | 302-79-4 | ≥98% |
|
2011-10-25 | 17.543287906690 | retinoic-acid | ATRA; Tretinoin; NSC 122758; Vitamin A Acid; all-trans Retinoic Acid; NSC 122578 | ligans receptor cancers development reproduction immunity gene expressions 7005-78-9 56573-65-0 187175-63-9 NSC-122758 NSC122758 AGN 100335 AGN100335 AGN-100335 aberel airol aknoten atragen cordes vas dermairol epi-aberel eudyna NSC 122578 NSC-122578 NSC122578 renova retacnyl retin A ro 1-5488 tretin M vesanoid vesnaroid vitamins A1 all trans | 17.543287906690 | ||
| 11002 |
Retinoid- |
- |
|
2011-08-09 | 23.618150194393 | retinoid-related-orphan-receptor-monoclonal-antibody-clone-4g419 | RAR-Related Orphan Receptor; ROR-γ; NR1F3 | antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells Nuclear Receptor RZR gamma Nuclear receptor RZR-gamma Nuclear Receptor RZR-gamma Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor gamma Retinoid-related orphan receptor-gamma Retinoid-Related Orphan Receptor-gamma RZR gamma RZR-gamma, Nuclear Receptor nuclear receptor ROR-gamma retinoic acid receptor-related orphan receptor gamma RORgamma | 23.618150194393 | |||
| 11003 |
Retinoid- |
- |
|
2011-08-09 | 23.618150194393 | retinoid-related-orphan-receptor-polyclonal-antibody | RAR-Related Orphan Receptor γ; NR1F3; ROR-γ | antibodies receptors DNA gamma amino acids transcription factors ROR proteins ligands Fas IL2 RORA RORB tissues muscles lymph nodes cells RAR Nuclear Receptor RZR gamma Nuclear receptor RZR-gamma Nuclear Receptor RZR-gamma Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor gamma Retinoid-related orphan receptor-gamma Retinoid-Related Orphan Receptor-gamma RZR gamma RZR-gamma, Nuclear Receptor nuclear receptor ROR-gamma retinoic acid receptor-related orphan receptor gamma RORgamma | 23.618150194393 | |||
| 11078 |
RORα Polyclonal Antibody (aa 220- |
- |
|
2012-04-19 | 104.444444444444 | ror-polyclonal-antibody-aa-220-270 | NR1F1; RAR-Related Orphan Receptor A; RZR-α | receptors retinoic acids NR1 subfamily nuclear hormones DNA binding domains genes expression cells functions NM23-2 NM23-1 CDK7 NCOA3 NCOA6 coactivators mesenchymal stem cells bones marrow acute promyelocytic leukemia APL western blots blotting Nuclear Receptor RZR alpha Nuclear receptor RZR-alpha Nuclear Receptor RZR-alpha Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor alpha Retinoid-related orphan receptor-alpha Retinoid-Related Orphan Receptor-alpha RZR alpha RZR-alpha, Nuclear Receptor nuclear receptor ROR-alpha retinoic acid receptor-related orphan receptor alpha RORalpha | 104.444444444444 | |||
| 11077 |
RORα Polyclonal Antibody (aa 80- |
- |
|
2012-04-05 | 104.444444444444 | ror-polyclonal-antibody-aa-80-120 | receptors retinoic acids NR1 subfamily nuclear hormones DNA binding domains genes expression cells functions NM23-2 NM23-1 CDK7 NCOA3 NCOA6 coactivators mesenchymal stem cells bones marrow acute promyelocytic leukemia APL western blots blotting Nuclear Receptor RZR alpha Nuclear receptor RZR-alpha Nuclear Receptor RZR-alpha Nuclear receptor subfamily 1 group F member 1 Retinoid Related Orphan Receptor alpha Retinoid-related orphan receptor-alpha Retinoid-Related Orphan Receptor-alpha RZR alpha RZR-alpha, Nuclear Receptor nuclear receptor ROR-alpha retinoic acid receptor-related orphan receptor alpha RORalpha | 104.444444444444 | ||||
| 71740 | Rosiglitazone | 122320-73-4 | ≥98% |
|
156.772103540003 | rosiglitazone | BRL 49653 | BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome atherosclerosis endocrinology | 156.772103540003 | |||
| 10011343 |
Rosiglitazone- |
- | >99% deuterated product |
|
2009-04-04 | 37.339193370166 | rosiglitazone-d5-maleate | SPI TZDs thiazolinedions PPARg PPAR.gamma. PPARgamma selective ligand insulin resistance anti-inflammatory | 37.339193370166 | |||
| 71742 | Rosiglitazone (potassium salt) | 316371-84-3 | >98% |
|
62.633134103465 | rosiglitazone-potassium-salt | BRL49653 BRL-49653 ligands ppar.gamma. ppargamma receptors antagonists antidiabetic nuclear receptors diabetes peroxisome salts thiazolidinediones atherosclerosis endocrinology | 62.633134103465 | ||||
| 10922 | SR 1001 | - | ≥98% |
|
2011-06-28 | 59.075591160220 | sr-1001 | inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 | 59.075591160220 | |||
| 10026 | T0070907 | 313516-66-4 | ≥98% |
|
44.348055248618 | t0070907 | T-0070907 nuclear receptors antagonist PPARgamma PPAR.gamma. peroxisome proliferator-activated selective selectivity thiazolidinediones TZDs inhibits inhibition inhibitors atherosclerosis endocrinology | 44.348055248618 | ||||
| 71810 | T0901317 | 293754-55-9 | ≥98% |
|
179.821464088397 | t0901317 | agonists to901317 TO-901317 T-0901317 t0-901317 receptors lipid nuclear hormone LXR.alpha.nuclear receptors LXR.beta. LXRalpha LXRbeta atherosclerosis | 179.821464088397 | ||||
| 11629 | Tamoxifen (citrate) New | 54965-24-1 | ≥98% |
|
2012-04-04 | 71.420949142938 | tamoxifen-citrate | ICI 46474; Nolvadex; Istubal; Noltam; Kessar; TMX; Valodex; Zemide | 7244-97-5 I.C.I.46474 citrate tamofen tamoplex tamox-puren tomaxasta Z-tamoxifen citrate nourytam ICI-46474 ICI46474 estrogen receptors cancers breasts agonists antagonists cholesterol modulators ER adjuvants bones uterus tissues cytochromes P450 CYP450 endoxifen cells apotosis autophagy differentiation | 71.420949142938 | ||
| 10007565 | Tetradecyl Phosphonate | 4671-75-4 | >98% |
|
2005-10-17 | 49.791160220994 | tetradecyl-phosphonate | pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter | 49.791160220994 | |||
| 10006321 | Tibolone | 5630-53-5 | >98% |
|
2005-01-25 | 52.222727272727 | tibolone | Liviella; Livial | steroids estrogens estradiols osteoporosis postmenopausal proestrogenic 3.alpha.-hydroxy 3a-hydroxy 3.beta.-hydroxy 3b-hydroxy androgenic climacteric bones symptoms menopause transition effects mass endocrinology | 52.222727272727 | ||
| 89730 | Trichostatin A | 58880-19-6 | ≥98% |
|
76.189505875335 | trichostatin-a | TSA | reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers | 76.189505875335 | |||
| 71750 | Troglitazone | 97322-87-7 | >98% |
|
69.170685082872 | troglitazone | ResulinTM | antidiabetic thiazolidinediones PPAR.gamma. PPARgamma ligands selective peroxisome proliferator-activated receptors diabetes TZD Resulin nuclear receptors atherosclerosis endocrinology | 69.170685082872 | |||
| 70730 | Wy 14643 | 50892-23-4 | ≥98% |
|
55.026270718232 | wy-14643 | Pirinixic Acid | activators peroxisome proliferator-activated receptors adipocytes obesity PPARalpha PPAR. nuclear receptors alpha. PPARgamma PPAR.gamma. PPARdelta PPAR.delta. atherosclerosis endocrinology wy14643 | 55.026270718232 |
Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA
Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640
Copyright 2012 Cayman Chemical Company
Quick Search